Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytek BioSciences Inc shares valued at $97,300 were purchased by McCombe William D. on Jun 02 ’25. At $2.78 per share, McCombe William D. acquired 35,000 shares. The insider’s holdings grew to 55,746 shares worth approximately $0.19 million following the completion of this transaction.
As published in a research note from TD Cowen on May 09, 2025, Cytek BioSciences Inc [CTKB] has been rated down from a Buy to a Hold and the price target has been revised to $4. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Sell”‘ outlook in a report released in late January. As of December 14, 2023, Stephens has initiated its “an Overweight” rating for CTKB. Earlier on July 19, 2023, Raymond James initiated its rating. Their recommendation was “a Mkt perform” for CTKB stock.
Analyzing CTKB Stock Performance
On last trading session,, Cytek BioSciences Inc [NASDAQ: CTKB] rose 3.10% to $3.33. The stock’s lowest price that day was $3.12, but it reached a high of $3.375 in the same session. During the last five days, there has been a surge of approximately 4.39%. Over the course of the year, Cytek BioSciences Inc shares have dropped approximately -41.88%. Shares of the company reached a 52-week high of $7.30 on 01/14/25 and a 52-week low of $2.37 on 05/23/25.
Support And Resistance Levels for Cytek BioSciences Inc (CTKB)
According to the 24-hour chart, there is a support level at 3.17, which, if violated, would cause prices to drop to 3.02. In the upper region, resistance lies at 3.43. The next price resistance is at 3.53. RSI (Relative Strength Index) is 55.04 on the 14-day chart, showing neutral technical sentiment.
Is Cytek BioSciences Inc subject to short interest?
Stocks of Cytek BioSciences Inc saw a sharp rise in short interest on 2025-05-30 jumping by 1.22 million shares to 5.41 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 4.19 million shares. A jump of 22.47% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.27.
Which companies own the most shares of Cytek BioSciences Inc (CTKB)?
In terms of Cytek BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 6.62 in the next 12 months, up nearly 105.11% from the previous closing price of $3.23. Analysts anticipate Cytek BioSciences Inc stock to reach 8 by 2025, with the lowest price target being 5.25. In spite of this, 4 analysts ranked Cytek BioSciences Inc stock as Buy at the end of 2025. On January 06, 2022, Piper Sandler assigned a price target of “an Overweight” to the stock and resumed coverage with a $20.
